Johnson & Johnson Gross Margin 1986-2025 | JNJ
Current and historical gross margin for Johnson & Johnson (JNJ) over the last 10 years. The current gross profit margin for Johnson & Johnson as of June 30, 2025 is %.
| Johnson & Johnson Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2025-06-30 |
$90.63B |
$61.55B |
67.92% |
| 2025-03-31 |
$89.33B |
$61.01B |
68.30% |
| 2024-12-31 |
$88.82B |
$61.35B |
69.07% |
| 2024-09-30 |
$87.70B |
$60.56B |
69.05% |
| 2024-06-30 |
$86.58B |
$59.79B |
69.06% |
| 2024-03-31 |
$85.65B |
$59.27B |
69.20% |
| 2023-12-31 |
$85.16B |
$58.61B |
68.82% |
| 2023-09-30 |
$76.31B |
$53.65B |
70.30% |
| 2023-06-30 |
$74.96B |
$52.73B |
70.35% |
| 2023-03-31 |
$77.46B |
$53.77B |
69.42% |
| 2022-12-31 |
$79.99B |
$55.39B |
69.25% |
| 2022-09-30 |
$77.21B |
$54.02B |
69.96% |
| 2022-06-30 |
$80.55B |
$56.28B |
69.87% |
| 2022-03-31 |
$79.85B |
$55.91B |
70.02% |
| 2021-12-31 |
$78.74B |
$55.34B |
70.28% |
| 2021-09-30 |
$91.45B |
$61.73B |
67.51% |
| 2021-06-30 |
$89.19B |
$59.75B |
67.00% |
| 2021-03-31 |
$84.21B |
$55.79B |
66.24% |
| 2020-12-31 |
$82.58B |
$54.16B |
65.58% |
| 2020-09-30 |
$80.86B |
$53.11B |
65.68% |
| 2020-06-30 |
$80.50B |
$52.86B |
65.66% |
| 2020-03-31 |
$82.73B |
$54.73B |
66.15% |
| 2019-12-31 |
$82.06B |
$54.50B |
66.42% |
| 2019-09-30 |
$81.71B |
$54.32B |
66.49% |
| 2019-06-30 |
$81.33B |
$54.22B |
66.67% |
| 2019-03-31 |
$81.59B |
$54.50B |
66.80% |
| 2018-12-31 |
$81.58B |
$54.49B |
66.79% |
| 2018-09-30 |
$81.38B |
$53.99B |
66.35% |
| 2018-06-30 |
$80.68B |
$52.96B |
65.64% |
| 2018-03-31 |
$78.69B |
$52.05B |
66.14% |
| 2017-12-31 |
$76.45B |
$51.01B |
66.72% |
| 2017-09-30 |
$74.36B |
$50.54B |
67.97% |
| 2017-06-30 |
$72.53B |
$50.15B |
69.15% |
| 2017-03-31 |
$72.17B |
$50.31B |
69.70% |
| 2016-12-31 |
$71.89B |
$50.10B |
69.69% |
| 2016-09-30 |
$71.60B |
$49.77B |
69.52% |
| 2016-06-30 |
$70.88B |
$49.32B |
69.58% |
| 2016-03-31 |
$70.18B |
$48.60B |
69.25% |
| 2015-12-31 |
$70.07B |
$48.54B |
69.27% |
| 2015-09-30 |
$70.52B |
$48.80B |
69.20% |
| 2015-06-30 |
$71.88B |
$49.99B |
69.55% |
| 2015-03-31 |
$73.59B |
$51.02B |
69.33% |
| 2014-12-31 |
$74.33B |
$51.59B |
69.40% |
| 2014-09-30 |
$74.43B |
$51.58B |
69.30% |
| 2014-06-30 |
$73.54B |
$50.75B |
69.01% |
| 2014-03-31 |
$71.92B |
$49.68B |
69.07% |
| 2013-12-31 |
$71.31B |
$48.97B |
68.67% |
| 2013-09-30 |
$70.52B |
$48.13B |
68.25% |
| 2013-06-30 |
$69.99B |
$47.35B |
67.65% |
| 2013-03-31 |
$68.59B |
$46.29B |
67.49% |
| 2012-12-31 |
$67.22B |
$45.57B |
67.78% |
| 2012-09-30 |
$65.92B |
$44.93B |
68.15% |
| 2012-06-30 |
$64.87B |
$44.41B |
68.45% |
| 2012-03-31 |
$65.00B |
$44.50B |
68.46% |
| 2011-12-31 |
$65.03B |
$44.67B |
68.69% |
| 2011-09-30 |
$64.42B |
$44.36B |
68.86% |
| 2011-06-30 |
$63.40B |
$43.81B |
69.11% |
| 2011-03-31 |
$62.13B |
$43.09B |
69.35% |
| 2010-12-31 |
$61.59B |
$42.80B |
69.49% |
| 2010-09-30 |
$62.49B |
$43.43B |
69.49% |
| 2010-06-30 |
$62.59B |
$43.69B |
69.80% |
| 2010-03-31 |
$62.50B |
$43.78B |
70.04% |
| 2009-12-31 |
$61.90B |
$43.45B |
70.20% |
| 2009-09-30 |
$60.53B |
$43.02B |
71.08% |
| 2009-06-30 |
$61.37B |
$43.52B |
70.92% |
| 2009-03-31 |
$62.58B |
$44.43B |
71.00% |
| 2008-12-31 |
$63.75B |
$45.24B |
70.96% |
| 2008-09-30 |
$64.52B |
$45.65B |
70.75% |
| 2008-06-30 |
$63.57B |
$45.20B |
71.10% |
| 2008-03-31 |
$62.25B |
$44.27B |
71.12% |
| 2007-12-31 |
$61.10B |
$43.34B |
70.95% |
| 2007-09-30 |
$58.82B |
$41.80B |
71.06% |
| 2007-06-30 |
$57.14B |
$40.74B |
71.30% |
| 2007-03-31 |
$55.37B |
$39.54B |
71.41% |
| 2006-12-31 |
$53.32B |
$38.27B |
71.76% |
| 2006-09-30 |
$52.25B |
$37.56B |
71.89% |
| 2006-06-30 |
$51.28B |
$36.88B |
71.93% |
| 2006-03-31 |
$50.67B |
$36.55B |
72.12% |
| 2005-12-31 |
$50.51B |
$36.50B |
72.27% |
| 2005-09-30 |
$50.66B |
$36.53B |
72.11% |
| 2005-06-30 |
$49.90B |
$35.94B |
72.02% |
| 2005-03-31 |
$48.62B |
$35.02B |
72.02% |
| 2004-12-31 |
$47.35B |
$33.87B |
71.54% |
| 2004-09-30 |
$45.85B |
$32.63B |
71.16% |
| 2004-06-30 |
$44.75B |
$31.74B |
70.91% |
| 2004-03-31 |
$43.60B |
$30.78B |
70.59% |
| 2003-12-31 |
$41.86B |
$29.69B |
70.91% |
| 2003-09-30 |
$40.01B |
$28.55B |
71.35% |
| 2003-06-30 |
$38.64B |
$27.54B |
71.28% |
| 2003-03-31 |
$37.38B |
$26.66B |
71.34% |
| 2002-12-31 |
$36.30B |
$25.85B |
71.22% |
| 2002-09-30 |
$35.12B |
$24.97B |
71.09% |
| 2002-06-30 |
$34.10B |
$24.16B |
70.86% |
| 2002-03-31 |
$33.21B |
$23.48B |
70.71% |
| 2001-12-31 |
$32.32B |
$22.74B |
70.35% |
| 2001-09-30 |
$31.20B |
$21.94B |
70.31% |
| 2001-06-30 |
$30.58B |
$21.52B |
70.38% |
| 2001-03-31 |
$30.07B |
$21.12B |
70.24% |
| 2000-12-31 |
$29.54B |
$20.66B |
69.94% |
| 2000-09-30 |
$29.30B |
$20.32B |
69.35% |
| 2000-06-30 |
$28.75B |
$19.93B |
69.32% |
| 2000-03-31 |
$28.05B |
$19.41B |
69.18% |
| 1999-12-31 |
$27.47B |
$19.03B |
69.27% |
| 1999-09-30 |
$27.06B |
$18.75B |
69.29% |
| 1999-06-30 |
$25.99B |
$17.95B |
69.07% |
| 1999-03-31 |
$24.89B |
$17.14B |
68.84% |
| 1998-12-31 |
$24.00B |
$16.50B |
68.76% |
| 1998-09-30 |
$23.16B |
$15.94B |
68.82% |
| 1998-06-30 |
$22.93B |
$15.72B |
68.55% |
| 1998-03-31 |
$22.75B |
$15.60B |
68.55% |
| 1997-12-31 |
$22.63B |
$15.48B |
68.39% |
| 1997-09-30 |
$22.50B |
$17.10B |
75.98% |
| 1997-06-30 |
$22.32B |
$16.95B |
75.94% |
| 1997-03-31 |
$22.00B |
$14.93B |
67.86% |
| 1996-12-31 |
$21.62B |
$14.60B |
67.54% |
| 1996-09-30 |
$20.96B |
$12.40B |
59.13% |
| 1996-06-30 |
$20.30B |
$11.90B |
58.64% |
| 1996-03-31 |
$19.68B |
$13.17B |
66.94% |
| 1995-12-31 |
$18.84B |
$12.61B |
66.91% |
| 1995-09-30 |
$18.09B |
$12.07B |
66.72% |
| 1995-06-30 |
$17.39B |
$11.55B |
66.41% |
| 1995-03-31 |
$16.54B |
$10.98B |
66.35% |
| 1994-12-31 |
$14.97B |
$9.67B |
64.61% |
| 1994-09-30 |
$14.41B |
$9.29B |
64.45% |
| 1994-06-30 |
$13.88B |
$8.93B |
64.35% |
| 1994-03-31 |
$13.51B |
$8.70B |
64.39% |
| 1993-12-31 |
$14.14B |
$9.35B |
66.11% |
| 1993-09-30 |
$14.11B |
$9.35B |
66.23% |
| 1993-06-30 |
$14.08B |
$9.32B |
66.17% |
| 1993-03-31 |
$13.96B |
$9.23B |
66.14% |
| 1992-12-31 |
$13.75B |
$9.08B |
65.99% |
| 1992-09-30 |
$13.40B |
$8.88B |
66.31% |
| 1992-06-30 |
$13.04B |
$8.63B |
66.21% |
| 1992-03-31 |
$12.66B |
$8.37B |
66.17% |
| 1991-12-31 |
$12.45B |
$8.24B |
66.22% |
| 1991-09-30 |
$12.00B |
$7.87B |
65.61% |
| 1991-06-30 |
$11.75B |
$7.69B |
65.44% |
| 1991-03-31 |
$11.54B |
$7.48B |
64.79% |
| 1990-12-31 |
$11.23B |
$7.30B |
64.95% |
| 1990-09-30 |
$11.00B |
$7.15B |
64.98% |
| 1990-06-30 |
$10.59B |
$6.87B |
64.94% |
| 1990-03-31 |
$10.15B |
$6.60B |
65.00% |
| 1989-12-31 |
$9.76B |
$6.28B |
64.33% |
| 1989-09-30 |
$9.49B |
$6.12B |
64.50% |
| 1989-06-30 |
$9.23B |
$5.93B |
64.19% |
| 1989-03-31 |
$9.13B |
$5.82B |
63.73% |
| 1988-12-31 |
$9.00B |
$5.71B |
63.42% |
| 1988-09-30 |
$8.73B |
$5.47B |
62.65% |
| 1988-06-30 |
$8.57B |
$5.38B |
62.82% |
| 1988-03-31 |
$8.34B |
$5.27B |
63.17% |
| 1987-12-31 |
$8.01B |
$5.06B |
63.09% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
